SGCB and chronic obstructive pulmonary disease: These preliminary data, together with the potential effectiveness of inhaled pulmonary vasodilators led to the currently ongoing clinical trial conducted to assess the effect of inhaled sGC stimulator on exercise capacity in COPD-associated PH (78).